GOLPH3 and hepatocellular carcinoma: Ying Gao et al. used both in vivo and in vitro assays to conclude that exosomal miR-494-3p derived from Golgi phosphoprotein 3 (GOLPH3)-overexpressing HCC cells promoted the angiogenesis ability of HUVECs and induced sorafenib resistance in HCC cells, which has important potential clinical value in improving therapeutic efficiency in HCC patients [177].